Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility. - Musuamba FT; Skottheim Rusten I; Lesage R; Russo G; Bursi R; Emili L; Wangorsch G; Manolis E; Karlsson KE; Kulesza A; Courcelles E; Boissel JP; et al. (CPT: pharmacometrics & systems pharmacology, 2021)